China Pharma Holdings (CPHI) Operating Expenses (2010 - 2026)

China Pharma Holdings (CPHI) has reported Operating Expenses for 17 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses rose 168.16% year-over-year to $1.5 million; the trailing twelve-month figure through Jun 2026 stood at $4.8 million (up 73.47% YoY), and the FY2025 full-year result was $3.1 million, up 19.36% from the prior year.
• Operating Expenses rose to $1.5 million in Q2 2026 per CPHI's latest filing, from $1.4 million in the prior quarter.
• Across five years, Operating Expenses topped out at $1.5 million in Q2 2026 and bottomed at $309647.0 in Q2 2023.
• Historically, Operating Expenses has averaged $786350.2 across 5 years, with a median of $598980.0 in 2023.
• The sharpest annual moves came in 2023 and 2026: Operating Expenses sank 43.72% in 2023, then surged 168.16% in 2026.
• Over 5 years, Operating Expenses stood at $1.2 million in 2022, then declined by 8.78% to $1.1 million in 2023, then decreased by 6.32% to $1.0 million in 2024, then jumped by 30.47% to $1.4 million in 2025, then gained by 12.17% to $1.5 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $1.5 million, $1.4 million, and $1.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.